About Prism Molecular
One of the foundations of Prism Molecular is that we provide highly accurate results and actionable information at a time when your patients need it most. Our team of healthcare professionals— including M.D., Ph.D, infectious disease specialists, and other professional clinicians—has diligently tailored and continually innovate comprehensive, patient-centric testing solutions based on feedback from our national client-base. Prism Molecular is prepared to meet the evolving needs of healthcare providers and consumers with solutions that are evolving, proven, actionable, and digitally-enabled. When you need trusted information to make clear, confident health decisions, consider Prism Molecular your source.

Prism Mission
At Prism Molecular, we aim to quickly, efficiently, and accurately provide cutting-edge medicine to our patients and partners while staying at the forefront of innovation.

Proactive Antimicrobial Stewardship
Antimicrobial resistance (AMR) is truly a global problem that requires urgent action from policymakers and the health community to avoid preventable deaths. The Prism Molecular ABx Advantage gene panel is designed to detect major classes of antibiotic resistance. This panel can identify the presence of specific resistance genes that are involved in drug inhibition. The Prism Molecular ABx Advantage gene panel has 11 antibiotic resistance genes belonging to amino glycoside, β-lactam, fluroquinolone, macrolide, tetracyline, vancomycin, and multi-drug resistance classifications. The multiplex PCR test takes less than 3 hours to complete. After, the data is used for providing antibiotic resistance stewardship. The OneChoice report powered by Arkstone Medical Solutions for the ABx Advantage gene panel converts PCR data into simple interpretations for physicians to help them make better treatment choices. The patent-pending technology is a combinations of software, Artificial intelligence, and human expertise.
